Page 2 - Rick Eiswirth News Today

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

(Forsyth County, GA) With the opening of the new Alimera Sciences headquarters in Halcyon, Forsyth County has become the home of a global pharmaceutical company. Alimera leadership team representatives and local leaders celebrated the new facility with a ribbon-cutting ceremony on May 9 Located in the 1200 office building next to Town Square, Alimera’s space now has a fresh, contemporary appeal as innovative as the company itself.

Alimera Sciences, Inc (NASDAQ:NASDAQ:ALIM) Q1 2022 Earnings Conference Call May 09, 2022, 9:00 AM ET Company Participants Scott Gordon - CORE IR Richard Eiswirth - President and Chief...

04.02.2022 - ATLANTA, Feb. 04, 2022 (GLOBE NEWSWIRE) - Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera”), a global pharmaceutical company whose mission is to be invaluable to patients, physicians and partners concerned with retinal health and maintaining ...

ALIM earnings call for the period ending September 30, 2021.

ALIM earnings call for the period ending September 30, 2021.

Operator Ladies and gentlemen, thank you for standing by. Good morning and welcome to Alimera Sciences First Quarter Fiscal Year 2021 Financial Results and Corporate Update Conference Call. [Operator Instructions] After todays presentation, there will be an opportunity to ask questions. [Operator Instructions] Participants of this call are advised that the audio of this conference call is being broadcast live over the Internet and is also being recorded by a playback-purposes. A webcast replay ...

Alimera Sciences Continues to Execute on Its Expansion Strategy in Denmark and Luxembourg, and Achieves Extended Reimbursement in Ireland March 17, 2021 08:00 ET | Source: Alimera Sciences, Inc. Alimera Sciences, Inc. Alpharetta, Georgia, UNITED STATES ATLANTA, March 17, 2021 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera”), a pharmaceutical company that specializes in the commercialization and development of prescription op...

Alimera Sciences Continues to Execute on Its Expansion Strategy in Denmark and Luxembourg, and Achieves Extended Reimbursement in Ireland March 17, 2021 08:00 ET | Source: Alimera Sciences, Inc. Alimera Sciences, Inc. Alpharetta, Georgia, UNITED STATES ATLANTA, March 17, 2021 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera”), a pharmaceutical company that specializes in the commercialization and development of prescription op...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Alimera Sciences Continues Global Geographic Expansion With Launch of ILUVIEN in Finland for ... Alimera Sciences, Inc.February 18, 2021 GMT ATLANTA, Feb. 18, 2021 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a pharmaceutical company that specializes in the development and commercialization of prescription ophthalmic pharmaceuticals, announces that ILUVIEN is now available in F...